national Federation of Clinical Neurophysiology committee's two EPs of choice, which together form the recommended minimum EP test battery for the assessment of neurological status and prediction of outcome in comatose patients. 4 The success of the ABR in this role appears to result from the following factors. 1) Death or survival in a persistent vegetative state occurs in the majority (Ͼ 95%) of comatose patients in whom obliteration of ABR, including or excluding Waves I, or I and II, is demonstrated after stimulation of either ear. The few individuals who recover generally suffer from severe neurological disabilities. 2) Death, survival in a persistent vegetative state, or severe disability occurs in the majority (65-100%) of individuals in whom the loss of Waves IV and V, abnormally increased ABR interwave latencies (I-III, III-V, and I-V), diminished V/I amplitude ratio, or loss of Waves IV and V are demonstrated. 3) Absent-to-moderate neurological deficits occur in the majority (approximately 65-70%) of patients in whom ABR signals are normal after stimulation of either ear during the acute stage of traumatic, cerebrovascular, or hypoxic-ischemic coma.
The ABR test is noninvasive, safe, mobile, brief, objective, reliable, a sensitive and comprehensive index of neurological status, anatomically specific, highly independent of level of consciousness, highly resistant to the effects of drugs, cost-effective, and it has the potential to be automated. 4, 5, [12] [13] [14] 22, 27 Limitations of the ABR as a Predictor of Outcome in Patients With Severe ACHI. Possibly the greatest limitation of the ABR as a predictor of outcome in patients with severe ACHI (at least numerically) is that 30 to 35% of these patients who present with normal ABR results on their initial assessment later die or remain in a persistent vegetative state. Such figures render a normal ABR on initial assessment in patients with severe ACHI of little use for prediction of outcome.
The poor sensitivity and specificity of the normal ABR finding could be the result of the absence of an eighth cranial nerve and/or ABR abnormality, or it could result from an insensitive definition of normal. The latter hypothesis is supported by a closer analysis of the literature on ABR in head-injured patients.
The majority of the literature on the ABR in severe ACHI has defined a normal ABR by using unnecessarily simple criteria, such as descriptions of the ABR waveform only, 8, 9, 13 ranking of ABR results on an ordinal scale, 1, 10, 19, 27 counting of waves present only, 10, 11, 20, 24 and the analysis of ABR latencies only and not amplitudes. 1, 8, 19, 27 The use of such oversimplified analysis methods has often been driven by the need for a simple, almost foolproof procedure that allows for easier ABR analysis in the often difficult A&E and ICU environments. Such a requirement falls away, however, in patients who present with a normal ABR, as defined by Waves I, III, and V latency measures. By definition, these normal ABRs contain all the necessary ABR information, in an easily identifiable form, to allow the use of higher-level analysis methods.
Higher-Level ABR Analysis: Latency and Amplitude Data, and DFA
The simplest method of achieving higher-level ABR analysis is to use more ABR information, and the simplest way to use more ABR information is to use both ABR latencies and amplitudes. To use amplitude variables, however, the problem of their inherent variability must be overcome. This could be achieved using multivariate statistical methods that not only analyze variables in isolation, but also in combination, therefore allowing for greater analysis of variable interaction. This is not fully achieved with standard clinical ABR analysis methods.
Of the many multivariate statistical analysis methods available, DFA was chosen for this study because it represents the most frequently used higher-level statistical analysis method in the literature on head injury. 18, 19, 24, 27, 29 The DFA is used to determine which variables discriminate between two or more naturally occurring groups, and then those variables are used to predict individual subject group membership, ideally of new cases. In addition, DFA allows for variable interaction without assuming independence, variable ranking according to prognostic significance, and calculations of predictive confidence levels.
Aims of the Study
In an attempt to improve the predictive accuracy of the normal ABR regarding short-term outcome in patients with severe ACHI after intracranial hematoma removal, in this study we had the following goals. 1) To record ABR signals with 90-dBnHL click stimuli from each ear of patients who were between 18 and 60 years of age, immediately after their admission to a neurosurgical ICU following severe ACHI and removal of an intracranial hematoma. 2) To select approximately 60 patients who presented with ABR signals within normal limits, and to record their full medical details for further study. 3) To record each patient's outcome at the time of discharge from the ICU as ACHI-lived or ACHI-died. 4) To determine the predictive accuracy of the medical and ABR findings by using DFA. 5) To determine if DFA improved the predictive accuracy of the normal ABR results with regard to short-term outcome in patients with severe ACHI after intracranial hematoma removal. 
Clinical Material and Methods

Patient Sample
Convenience sampling was performed in 68 adult patients with severe ACHI who were admitted to the neurosurgical ICU of the Chris Hani Baragwanath Hospital, Soweto, South Africa, between September 1999 and January 2000. Unconditional ethics clearance was given by the University of the Witwatersrand Committee for Research on Human Subjects (Medical) to conduct the study (protocol number M981023).
Selection Criteria
The selection criteria were aimed to facilitate sampling in the most available type of severe ACHI within our institution's neurosurgical ICU and to minimize excessive sample heterogeneity. As a result, the patients with severe ACHI were required to meet the following criteria: 1) to be between 18 and 60 years of age; 14 2) to have been admitted to the hospital within 12 hours of sustaining a severe ACHI (GCS 17 score Ͻ 9 on admission, but not necessarily at the time of ABR assessment) with an intracranial hematoma requiring surgical evacuation; 3) to be assessable by ABR testing within 12 hours of surgery; 4) to have a body temperature of 37 Ϯ 1˚C at the time of ABR testing; 14 5 ) not to have received any drugs known to influence significantly the ABR; 14 6 ) with the obvious exception of their ACHI, to have no identifiable case history, past or present, of auditory dysfunction, neural dysfunction, or head injury that could affect the ABR results 14 (the limitations of our ability to confirm this accurately were noted); and 7) to have an ABR within normal limits bilaterally to 90 dBnHL click stimuli (within 2 SDs of the matched mean values defined by previously obtained control data 30 ). If the patient died, the cause of death must have been directly related to the ACHI, and not to any other complication (for example, sepsis, pneumonia, and so on). Tables 1 and 2 show descriptions of the 68 patients studied. The average time spent by these individuals in the neurosurgical ICU before being classified into their outcome group was 28.4 Ϯ 9.3 hours for those whose outcome was death or vegetative state, and 260.3 Ϯ 82.7 hours for those whose outcome was disabled and who were discharged from the ICU.
Characteristics of Patients
All procedures were conducted in the Chris Hani Baragwanath Hospital A&E and neurosurgical ICU wards, Johannesburg, South Africa. Before ABR assessment, all patients had undergone typical A&E and neurosurgical ward medical treatment and rehabilitative protocols as outlined later. These measures were defined as pre-or postoperative.
Preoperative Treatment in the A&E Ward
Procedures performed before intracranial surgery typically consisted of the following (not always in the same order): 1) as detailed a history as possible from whatever personnel, family, or friends were available; 2) cardiopulmonary stabilization by airway, breathing, and circulation management, with intubation and ventilation where necessary; 3) general examination and management of associated injuries by the use of catheters, physiological measures, and diagnostic films; 4) neurological examination with the GCS and pupillary tests; 5) application of therapeutic agents; 6) diagnostic assessment by CT scanning (and occasionally angiography when necessary); and 7) transfer to the surgical wards for evacuation of the intracranial hematoma.
Postoperative Treatment in the Neurosurgical ICU
After removal of the intracranial hematoma, the patients with severe ACHI were moved to the neurosurgical ICU. Assessment and monitoring by neurosurgeons and ICU nurses typically consisted of similar processes to those used preoperatively (not always in the same order), plus the following: 1) management of ICP and cerebral perfusion pressure by reduction of cerebral blood volume and/or brain tissue water by hyperventilation or diuresis with mannitol (ICP monitors were rarely used, mainly because of financial and supply difficulties); 2) sedation and seizure control by application of the anticonvulsant Epamutin, the analgesic DF118, and the benzodiazepines diazepam and Dormicum; 3) antibacterial therapy, typically with cephazolin; 4) nutritional support by intravenous drip feeds; 5) gastric support, typically with the antiulcer drug cimetidine; and 6) bowel motion support, typically by the use of a stool loosener.
Postoperative ABR Protocol
All patients who met the selection criteria underwent ABR testing at their bedside within 12 hours of admission to the neurosurgical ICU. The ABR test protocol and stimulus and recording parameters were as follows.
Stimulus Parameters. Stimulus duration and type: acoustic click driven by a 0.1-msec, square-wave electrical click; stimulus polarity: alternating; stimulus rate: 21 clicks per second; test ear stimulus level: 90 dBnHL (as indicated by the EP software, no attempt was made to measure the stimulus intensity at the tympanic membrane); nontest ear masking: white noise at 40 dBnHL below test ear stimulus level.
Recording Parameters. Recording channels: 1; time epoch: 15 msec; pre-/poststimulus delay: nil; analog-to-digital conversion sample points: 512 (the maximum allowable on the Biologic Evoked Potential software); gain: 150,000 (sensitivity or artifact level Ϯ 16.3 V); high-frequency cut filter: 3000 Hz; low-frequency cut filter: 30 Hz; artifact rejection: enabled; 50-Hz main power notch filter: in; responses averaged: 2048. To remove any possible stimulus artifact in the beginning of the ABR trace, the first 20 sample points were preset (blocked) to zero. Two ABR recordings were selected from each ear of each patient.
Data Collection
During the A&E ward assessment, which was performed before the ABR assessment, we recorded CT descriptors of the length of the largest hematoma axis (in millimeters), number of hematomas (single or multiple), degree of midline and/or tentorial brain shift (in millimeters), and location of hematoma (supra-or subtentorial and extra-or intracerebral), as well as x-ray evidence of the presence or absence of a skull fracture.
At the time of ABR testing in the neurosurgical ICU, the following data were collected: patient age (years); systolic and diastolic BP (millimeters of mercury); pulse rate (beats/ minute); body temperature (degrees centigrade); GCS total score (sum of the best responses obtained within each of the eye, verbal, and motor component); GCS eye response score (best of the right or left eye responses); GCS verbal response score (scored as 1 if the patient was intubated [noted as a limitation of the GCS data collection]); and GCS motor response score (best of the right or left, arm or leg, motor scores). 2 We also obtained pupillary size scores (0, abnormal bilaterally; 1, abnormal unilaterally; or 2, normal bilaterally), 3, 6 with abnormal considered to be anything but normal, that is, pinpoint, small, dilated, or irregular; pupillary light reaction scores (0-2, scored as for size), with abnormal considered to be anything but normal, that is, sluggish or fixed; respiratory rate (breaths/minute); and blood PO 2 and PCO 2 pressure (millimeters of mercury). The ICP was not recorded because this measure was rarely obtainable in our hospital's A&E and neurosurgical ICU wards. Also measured were ABR Waves I, III, and V absolute latencies (milliseconds) and amplitudes (preceding-troughto-peak [a] and peak-to-following-trough [b] amplitudes and the overall root mean square amplitude [microvolts]), and I-III, III-V, and I-V interwave latencies (milliseconds). All ABR values were averaged among the four traces recorded in each patient (two traces in each ear) to give single ABR latency and amplitude values for each patient.
Data Analysis
On discharge from the neurosurgical ICU (due to death or transfer to a lower-care ward), the patients with severe ACHI were placed into one of two outcome categories based on the neurosurgeon's report and the five categories of the GOS 16 -good outcome, moderate or severe disability (ACHI-lived), or vegetative state or death (ACHI-died).
Descriptive statistics were calculated for all measured variables in both groups, and forward stepwise, jackknife DFAs (p Ͻ 0.05) were conducted to determine which variables from the ABR, medical, and combined ABR and medical measures discriminated between the two outcome groups in patients with severe ACHI. In addition, an assessment of the reliability, or confidence level, of each individual DFA prediction was made (the posterior probability). This concept was important because if two prognostic indicators produce the same number of correct predictions, then the one that provides correct predictions at a higher level of confidence must be regarded as superior. 11, 18, 19, 21, 27 Despite the time that elapsed and recovery events that occurred between pre-and postoperative data collection, the CT measures of hematoma size, midline/tentorial brain shift (both in millimeters), and number of lesions were included in the final DFA based on previously shown correlations between initial CT results and outcome. 11, 24 The CT measures describing lesion location were excluded because of their skewed distribution (all 68 patients had supratentorial, extracerebral lesions, but only 10 had subtentorial and only nine had intracerebral lesions) and the nominal nature of these variables, which prevented their use in the DFA models. Similarly, all ABR I-III, III-V, and I-V interwave latencies and Wave V/I amplitude ratios were excluded because of their redundancy in the DFA; pupillary light reaction scores were excluded because this score was 0 (abnormal bilaterally) in all patients in the ACHI-died group, resulting in zero group variance; and blood PO 2 and PCO 2 were excluded because in large numbers of patients these measures were maintained at artificially high and low levels, respectively, by artificial ventilation. Tables 3 and 4 show the ABR and medical measure descriptive results, respectively, for the ACHI-died and ACHI-lived groups. All patients in the ACHI-died group fell under the GOS dead category. Tables 5 and 6 show DFA results for the ABR measures in the ACHI-lived compared with ACHI-died groups, Table  7 shows DFA results for the medical measures in both groups, and Table 8 shows results for the medical and ABR measures combined. (Table 6) . Individually, Wave I and V latencies separated the ACHIlived from the ACHI-died group at a highly significant level (p Ͻ 0.000005 for both latencies), whereas individual ly, Wave IIIb amplitude did not separate the ACHI groups (p = 0.17).
Results
Descriptive Results
Discriminant Function Analyses
The medical measures DFA model (Table 7) , which contained pulse, GCS motor score, and diastolic BP separated the ACHI-lived from the ACHI-died group at a highly significant level (p Ͻ 0.000005: pulse, p Ͻ 0.000005; GCS motor score, p Ͻ 0.00005; and diastolic BP, p Ͻ 0.05).
The combined ABR and medical measures DFA model (Table 8) , which contained pulse, GCS motor score, latency Waves V and I, and amplitude Wave IIIb, separated the ACHI-lived from the ACHI-died group at a highly significant level (p Ͻ 0.000005: pulse, p Ͻ 0.000005; GCS motor score, p Ͻ 0.00001; latency Wave V, p Ͻ 0.0001; latency Wave I, p Ͻ 0.0005; and amplitude Wave IIIb, p Ͻ 0.005).
Discussion
Discriminant Function Analyses: ABR
The ABR DFA results compared well with those of the medical measures at group and case-by-case levels, but showed a poorer number of correct predictions at the 90% or higher confidence level. Such a reduction in confidence identifies the ABR measures as being useful but inferior to the medical measures as predictors of outcome in this study's sample.
The highly successful results achieved using the normal ABR signals were surprising considering the belief stated in the literature that a normal ABR is the least prognostic of the possible ABR results. Generally, a normal ABR is thought to be suggestive of patient survival, with only a 65 to 70% sensitivity rate. 4, 5, 14, 22, 27 The reason for this study's highly successful ABR prediction rate could be the full use of ABR amplitude and latency data (more information) in a DFA (more variable in- teraction), compared with the use in the majority of the literature of simple descriptive, wave-count, or ordinal scale rating data (less information) in descriptive, chi-square, or univariate analysis of variance (less variable interaction). This suggestion was supported by two other findings. The first was the presence of Wave IIIb amplitude in the final ABR model. The ABR amplitudes in patients with both normal and abnormal ABRs are regularly identified in the literature as being notoriously variable, therefore making them unreliable measures for case-by-case analyses. 14, 15, 23 The ABR amplitudes in this study were also highly variable, but when included in a multivariate DFA, Wave IIIb amplitude gained predictive value. The second finding was that when analyzed as single variables in separate, univariate DFAs, Wave I and V latencies showed reduced case-bycase prediction rates, and Wave IIIb showed no significance at all. Therefore, the interactions between ABR amplitude and latency components added predictive value to the ABR DFA model. Although other authors have had similar success in using higher-level analysis methods to improve the predictive accuracy of the ABR in severe ACHI and coma to between 60 and 100%, 19, 26, 27, 29 none have used ABR amplitudes and latencies in a DFA of normal ABR responses only. These other studies, therefore, can only offer indirect support for our findings.
In opposition to our study's findings are Hall 12 and Facco, et al. 7 Hall showed no significant differences (p Ͻ 0.05) between normal ABR latencies and amplitudes in his severe ACHI-lived compared with ACHI-died groups, whereas Facco, et al., predicted that 95% of severe head injury survivors would have a Wave I-V interwave latency ranging between 3.82 and 4.5 msec. Reasons for these disagreements could lie in patient sample differences, and/or, as has been argued earlier in this article, the use of higher-level multivariate analysis (DFA) in this study compared with simpler univariate statistical analyses in the studies by Hall and Facco, et al.
The inclusion of Wave I and V latencies and Wave IIIb amplitude indicates an active input of three factors, as follows: 1) ABR latencies and amplitudes; 2) early and late ABR components; and 3) the eighth cranial nerve, lowbrainstem and high-brainstem generator sites. These results were consistent with similar reports citing the predictive accuracy of these measures in abnormal ABR results. 12, 19, 22, 26, 27, 29 
Discriminant Function Analyses: Medical Measures
The medical measure DFA results were consistent with previous studies showing similar group differences and 70 to 100% case-by-case correct prediction levels (at 50-100% confidence levels). 11, 18, 19, 21, 27 This study's results were particularly successful, however. Reasons for this study's high success rate could have been related to the imposed intracranial hematoma selection criterion, the absence in the ACHI-died group patients in the vegetative state according to the GOS, and/or the short-term nature of the prediction.
Generally, the inclusion of pulse, GCS motor score, and diastolic BP was in agreement with findings in previously published literature, 11, 18, 19, 21, 27 which identify these medical measures in various combinations as having prognostic significance. Although this study adds support to the widely recommended inclusion of the GCS motor score in predictive models, it is one of a smaller number of studies to have included pulse and diastolic BP. 21, 25, 28 Contributing to this, however, is the complete lack of consideration of these variables in much of the previous literature.
Although pupillary response was excluded from the DFA because of its zero variance, it was bilaterally abnormal in all 38 of the ACHI-died patients, but in only five of 38 ACHI-lived patients, therefore identifying it as having been highly predictive of short-term outcome. This is consistent with reports in the literature that the loss of the pupillary light response carries a markedly worse prognosis, with progressively greater loss of pupillary reaction (particularly unilateral to bilateral) indicating progressively poorer outcome.
11,21,24
Discriminant Function Analyses: Combined ABR and Medical Measures
The combined ABR and medical measure DFA results were significantly better than those of either the ABR or the medical measure DFAs alone, and provided nearly perfect predictive accuracy. Although the danger of overinterpretation must be kept in mind, this result identifies the presence of useful interactions between ABR and medical measures for predicting outcome in patients with severe ACHI after removal of intracranial hematomas.
Conclusions
The DFA of normal ABR wave latencies and amplitudes significantly improved this measure's prediction of outcome in patients with severe ACHI after surgical removal of intracranial hematomas. Without this analysis, the normal ABR results would have been considered to be of less predictive value.
These improvements could have resulted from the use of more ABR data (amplitudes and latencies) in a higherlevel statistical analysis (DFA). Supporting this hypothesis was the inclusion of an ABR amplitude measure in the final model, and the reduced predictive abilities of the individual ABR measures when analyzed using separate univariate DFAs.
Although predictions using the ABR DFA remained inferior in confidence to those of the medical measure DFA, predictions using the combined ABR and medical measures neared 100%, a level significantly better than either the medical or ABR measure alone. This supports the use of ABR (latencies and amplitudes) and medical measure DFAs to predict outcome in patients with severe ACHI who present with a normal ABR after surgical removal of intracranial hematomas. Such a conclusion contradicts comments in the general literature warning that complex monitoring methods are impractical and produce information that is only meaningful to specially trained personnel. 22 Although such comments are valid, enforcing overly simple analyses should not be promoted at the expense of test sensitivity and specificity.
A more complex monitoring method does not automatically mean the information produced is difficult to obtain, or that it is only meaningful to specifically trained personnel. The complex analysis of the ABR recommended by our study can be performed using any standard statistical (or spreadsheet) software, because it is a relatively straightforward DFA of ABR and medical measure variables. Once more widely accepted DFA predictive formulas are created, such analysis protocols could easily be built into any of the clinical ABR software currently available. In this way, the ABR signals could be labeled, medical measures added, and the DFA immediately performed. This would add only 10 to 15 minutes to the overall assessment time in patients with severe ACHI. Such time additions are usually acceptable in an ICU monitoring environment. 
